1Department of Surgery, Yonsei University College of Medicine, Seoul, Korea 2Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
Corresponding Author:
Seho Park ,Tel: +82-2-2228-2100, Fax: +82-2-313-8289, Email: psh1025@yuhs.ac
Received: September 23, 2011; Accepted: October 20, 2011.
Share :
ABSTRACT
Purpose : The aims of this study were to investigate clinicopathological characteristics and outcomes of
pregnancy-associated breast cancer (PABC) and to determine the implications of pregnancy itself on the prognosis
of PABC.
Methods : Clinicopathological features, treatment patterns, and survival of 14 PABC patients were compared to
those of 855 invasive ductal carcinoma (IDC) patients under 40 years of age, who were treated between 1987 and
2007, using a chi-square test, the Kaplan-Meier method, and Cox’s hazards models. PABC was defined as breast
cancer diagnosed during pregnancy or within the first year after delivery.
Results : Among 14 PABCs, 7 were diagnosed during pregnancy and 7, during the first postpartum year. The mean
duration of the symptoms was 7.6 months. The mean age at diagnosis of PABC and IDC under 40 years was 32.6
and 34.6 years, respectively (p=0.044). All PABCs were ductal type. Hormone receptors, treatment modalities, and
tumor and node stage were not statistically different between PABC and IDC under 40 years. Five-year diseasefree,
locoregional relapse-free, distant relapse-free, and overall survival of PABC was 57.1%, 71.3%, 56.4%, and
70.0%, respectively. Survival was not significantly different between two groups. In Cox°Øs models, PABC was not
associated with survival outcomes. Among PABCs, there was no statistical difference in survival between patients
diagnosed before and after delivery.
Conclusion : Pregnancy itself does not increase the risk of poorer outcomes among young breast cancer patients.
Vigilant diagnosis and multidisciplinary treatment should be recommended to best manage woman with PABC
and her baby.